中文名 | 拉坦前列腺素内酯二醇 |
---|---|
英文名 | (3aR,4R,5R,6aS)-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-one |
中文别名 |
2H-环戊并[B]呋喃-2-酮,六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊烷基]-,(3AR,4R,5R,6AS)-(...)
(3AR,4R,5R,6AS)-六氢-5-羟基-4-[(3R)-3-羟基-5-苯基戊基]-2H-环戊并[B]呋喃-2-酮 拉坦前列素内酯二醇 |
英文别名 |
(3aR,4R,5R,6aS)-5-Hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]hexahydro-2H-cyclopenta[b]furan-2-one
LatanoprostLactoneDiol 2H-Cyclopenta[b]furan-2-one, hexahydro-5-hydroxy-4-[(3R)-3-hydroxy-5-phenylpentyl]-, (3aR,4R,5R,6aS)- |
描述 | Latanoprost lactone diol 是合成 Latanoprost 的中间体。Latanoprost 是前列腺素 F2α 类似物,是一种前列腺素受体 (FP prostanoid receptor) 激动剂,可降低眼内压 (IOP)。 |
---|---|
相关类别 | |
参考文献 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 523.0±35.0 °C at 760 mmHg |
熔点 | 69-71ºC |
分子式 | C18H24O4 |
分子量 | 304.381 |
闪点 | 190.3±19.4 °C |
精确质量 | 304.167450 |
PSA | 66.76000 |
LogP | 0.60 |
蒸汽压 | 0.0±1.4 mmHg at 25°C |
折射率 | 1.568 |
~79% 145667-75-0 |
文献:Chirogate International Inc. Patent: EP1810967 A1, 2007 ; Location in patent: Page/Page column 20-21 ; |
~85% 145667-75-0 |
文献:Resul, Bahram; Stjernschantz, Johan; No, Kiyo; Liljebris, Charlotta; Selen, Goeran; et al. Journal of Medicinal Chemistry, 1993 , vol. 36, # 2 p. 243 - 248 |
~% 145667-75-0 |
文献:EP1886992 A1, ; Page/Page column 9 ; |
~% 145667-75-0 |
文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
~% 145667-75-0 |
文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
~% 145667-75-0 |
文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
~% 145667-75-0 |
文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |
~% 145667-75-0 |
文献:Journal of Medicinal Chemistry, , vol. 36, # 2 p. 243 - 248 |